2022
DOI: 10.1007/s00408-022-00586-3
|View full text |Cite
|
Sign up to set email alerts
|

Cough Characteristics and Healthcare Journeys of Chronic Cough Patients in Community-Based Populations in South Korea and Taiwan

Abstract: Purpose This study aimed to understand the cough characteristics and health journeys among community-based chronic cough (CC) patients, and their characteristics associated with healthcare visits. Methods A population-based cross-sectional study was conducted in 2020, using the South Korea and Taiwan National Health and Wellness Survey (NHWS) and CC surveys. Patients with current CC were defined by daily coughing for > 8 weeks in the past 12 months and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 36 publications
2
11
0
Order By: Relevance
“…In an analysis of a Midwestern academic medical institutional EHRs, US, opioid-containing cough suppressants were prescribed to 22.0% of patients with chronic cough and the odds ratio for at least one prescription was 2.9 for patients with chronic cough ( vs. non-chronic cough controls) ( 22 ). Similar prescription rates were reported from community-based populations of South Korea and Taiwan (11.9% and 28.2%, respectively) ( 12 ), but also a much higher rate reported from specialist clinics (pulmonologists, allergists, otolaryngologists, or gastroenterologists) in Southern California, US (58.9%) ( 11 ). The higher codeine prescription rates at specialist clinics (including the present study) may be attributed to healthcare journey or prior insufficient treatment responses of patients before visiting the referral centers ( 23 ).…”
Section: Discussionsupporting
confidence: 74%
See 1 more Smart Citation
“…In an analysis of a Midwestern academic medical institutional EHRs, US, opioid-containing cough suppressants were prescribed to 22.0% of patients with chronic cough and the odds ratio for at least one prescription was 2.9 for patients with chronic cough ( vs. non-chronic cough controls) ( 22 ). Similar prescription rates were reported from community-based populations of South Korea and Taiwan (11.9% and 28.2%, respectively) ( 12 ), but also a much higher rate reported from specialist clinics (pulmonologists, allergists, otolaryngologists, or gastroenterologists) in Southern California, US (58.9%) ( 11 ). The higher codeine prescription rates at specialist clinics (including the present study) may be attributed to healthcare journey or prior insufficient treatment responses of patients before visiting the referral centers ( 23 ).…”
Section: Discussionsupporting
confidence: 74%
“…In a recent retrospective administrative pharmacy and medical database analysis, antitussives including codeine were prescribed in 58.9% of chronic cough patients at specialist clinics in Southern California, US ( 11 ). The use of codeine- or hydrocodone-containing drugs was reported by 11.9% and 28.2% of chronic cough patients in community-based populations of South Korea and Taiwan, respectively ( 12 ). However, a prescription pattern of codeine, such as dose or treatment duration, has not been reported in detail.…”
Section: Introductionmentioning
confidence: 99%
“…Both conditions are also characterised by exacerbations which are often treated with prescription drugs, and this may partly explain their associations with repeated visits. The important role of quality-of-life in healthcare use and costs due to cough has been recognised also previously [ 4 , 17 , 18 ]. Routine quality-of-life assessment, as recommended in guidelines [ 14 , 19 ], may help to detect potential “high-cost patients” due to cough.…”
Section: Discussionmentioning
confidence: 95%
“…Indeed, 2022 witnessed the approval of the first-ever drug indicated for the treatment of refractory chronic cough [ 51 , 52 ]. LUNG continued its emphasis on high-quality cough-related research by featuring numerous articles, including those examining asthma-associated cough [ 21 , 22 ]; cough associated with IPF [ 53 ] and COVID19 [ 54 ]; methodology of objective cough counting [ 55 , 56 ]; cough-related healthcare utilization [ 57 , 58 ]; physiology [ 59 ]; and, studies of potential antitussive drugs [ 60 62 ].…”
mentioning
confidence: 99%